GlassScriptPhysician profile
Chris Hansen
NPI 1760455331
$646.72
in general payments reported to CMS, 2019-2025
14 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $114 · 2022: $94.94 · 2023: $105 · 2024: $143 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $128.63 | 2021-2025 | Aristada, Lybalvi |
| Lundbeck LLC | $124.06 | 2023-2025 | Rexulti, Abilify Asimtufii |
| Supernus Pharmaceuticals, INC. | $59.86 | 2025 | Qelbree |
| Braeburn INC. | $58.72 | 2025 | Brixadi |
| Amgen INC. | $45.68 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $43.51 | 2024 | Rexulti, Abilify Asimtufii |
| Bioxcel Therapeutics, INC. | $41.65 | 2023 | Igalmi |
| Takeda Pharmaceuticals U.S.A., INC. | $29.52 | 2022 | |
| Janssen Pharmaceuticals, INC | $26.84 | 2025 | Spravato |
| Ironshore Pharmaceuticals INC. | $25.63 | 2024 | |
| Harmony Biosciences LLC | $17.50 | 2024 | |
| Almatica Pharma LLC | $17.03 | 2024 | Loreev Xr |
| Lilly USA, LLC | $16.05 | 2021 | |
| Vapotherm INC | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.